KDA Group Inc. (TSXV: KDA) ("KDA" or the "Corporation"), a leader in innovative technological solutions for healthcare professionals, is pleased to announce a collaboration with AstraZeneca Canada to ...
as an ordinary resolution, THAT the appointment of Ernst & Young Hua Ming LLP as auditor of the Company for the fiscal year ending December 31, 2025 be ratified and that the directors of the Company ...
VCYT's Afirma and Decipher fuel strong test volume growth and a debt-free balance sheet, but rising macro costs and expenses temper the outlook.
According to MarketsandMarkets™, The report Single-molecule Real-time (SMRT) Sequencing Market is projected to grow from USD 2.92 billion ...
The analysis revealed that about 2 per cent of sperm from men in their early 30s contained disease-causing mutations. That ...
Looking back, the unifying insight across these experiences is simple: Lasting impact comes from ventures that genuinely ...
When disease begins forming inside the human body, something subtle happens long before symptoms appear. Individual molecules ...
Precision Psychiatry Market is projected to reach US$ 4.2 Bn by 2035, driven by rapid integration of AI and ML in psychiatric ...
News Medical on MSN
Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing
Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct ...
The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.
The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.
A study led by biomedical scientists at the University of California, Riverside, has shown for the first time that a father's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback